ClinicalTrials.Veeva

Menu

Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease

S

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Status

Completed

Conditions

CAM
Crohn's Disease

Treatments

Other: Control Group
Other: Treatment Group

Study type

Interventional

Funder types

Other

Identifiers

NCT01697761
SHACU-201202

Details and patient eligibility

About

The purpose of this study is to determine whether acupuncture or moxibustion therapies are effective in the treatment of active Crohn's disease. meanwhile, we are aim to observe the content of Inflammatory factors and Neurotransmitter before and after acupuncture and moxibustion therapy.

Full description

The purpose of this study is to determine whether acupuncture or moxibustion therapies are effective in the treatment of active Crohn's disease. meanwhile, we are aim to observe the content of Inflammatory factors and Neurotransmitter before and after acupuncture and moxibustion therapy.

Through treating active Crohn's disease by acupuncture and moxibustion therapies for 12 weeks, we are aim to observe the efficiency and the probably change of Inflammatory factors and Neurotransmitter of colonic mucosa and we may elucidate the mechanism of the efficiency of acupuncture and moxibustion therapy.

Enrollment

92 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18-70 years;
  • Crohn's Disease Activity Index [CDAI]>150 and <450;
  • not taking any medication or taking salicylates, prednisone ( dose≤ 15mg and at least have taken a month ), after entering the study the dose remained constant;
  • Not taking immunosuppressive agents or use " with " biological preparations within 3 months prior to entering the study
  • signing a written informed consent form.

Exclusion criteria

  • Severe Crohn's disease patients or patients in remission ( CDAI > 450 or < 150 );
  • The pregnancy or lactation period patients ;
  • patients associated with heart, brain, liver, kidney and hematopoietic system disease;
  • The psychiatric patients;
  • Patients with other serious diseases.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

92 participants in 2 patient groups

Treatment Group
Experimental group
Description:
treat by moxibustion and acupuncture
Treatment:
Other: Treatment Group
Control Group
Experimental group
Description:
treat by Sham acupuncture and moxibustion
Treatment:
Other: Control Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems